[1] |
OSTROM Q T, BAUCHET L, DAVIS F G, et al. The epidemiology of glioma in adults: a “state of the science” review[J]. Neuro Oncol, 2014, 16(7): 896-913.
doi: 10.1093/neuonc/nou087
|
[2] |
MALTA T M, DE SOUZA C F, SABEDOT T S, et al. Glioma CpG island methylator phenotype (G-CIMP): biological and clinical implications[J]. Neuro Oncol, 2018, 20(5): 608-620.
doi: 10.1093/neuonc/nox183
|
[3] |
SHI J, ZHANG Y, QIN B, et al. Long non-coding RNA LINC00174 promotes glycolysis and tumor progression by regulating miR-152-3p/SLC2A1 axis in glioma[J]. J Exp Clin Cancer Res, 2019, 38(1): 395.
doi: 10.1186/s13046-019-1390-x
|
[4] |
MIYAUCHI J T, TSIRKA S E. Advances in immunotherapeutic research for glioma therapy[J]. J Neurol, 2018, 265(4): 741-756.
doi: 10.1007/s00415-017-8695-5
pmid: 29209782
|
[5] |
LV Q L, WANG L C, LI D C, et al. Knockdown lncRNA DLEU1 inhibits gliomas progression and promotes temozolomide chemosensitivity by regulating autophagy[J]. Front Pharmacol, 2020, 11: 560543.
|
[6] |
FU C, LI D Y, ZHANG X N, et al. LncRNA PVT1 facilitates tumorigenesis and progression of glioma via regulation of miR-128-3p/GREM1 axis and BMP signaling pathway[J]. Neurotherapeutics, 2018, 15(4): 1139-1157.
doi: 10.1007/s13311-018-0649-9
pmid: 30120709
|
[7] |
CHEN P Y, LI X D, MA W N, et al. Comprehensive transcriptomic analysis and experimental validation identify lncRNA HOXA-AS2/miR-184/COL6A2 as the critical ceRNA regulation involved in low-grade glioma recurrence[J]. Onco Targets Ther, 2020, 13: 4999-5016.
doi: 10.2147/OTT.S245896
|
[8] |
LIU X, ZHU Q J, GUO Y, et al. LncRNA LINC00689 promotes the growth, metastasis and glycolysis of glioma cells by targeting miR-338-3p/PKM2 axis[J]. Biomedecine Pharmacother, 2019, 117: 109069.
|
[9] |
AKELLA N M, LE MINH G, CIRAKU L, et al. O-GlcNAc transferase regulates cancer stem-like potential of breast cancer cells[J]. Mol Cancer Res, 2020, 18(4): 585-598.
doi: 10.1158/1541-7786.MCR-19-0732
pmid: 31974291
|
[10] |
MOHIUDDIN I S, WEI S J, KANG M H. Role of OCT4 in cancer stem-like cells and chemotherapy resistance[J]. Biochim Biophys Acta Mol Basis Dis, 2020, 1866(4): 165432.
|
[11] |
SUN Z, WANG L, DONG L H, et al. Emerging role of exosome signalling in maintaining cancer stem cell dynamic equilibrium[J]. J Cell Mol Med, 2018, 22(8): 3719-3728.
doi: 10.1111/jcmm.13676
|
[12] |
LI W G, JIANG P F, SUN X L, et al. Suppressing H19 modulates tumorigenicity and stemness in U251 and U87MG glioma cells[J]. Cell Mol Neurobiol, 2016, 36(8): 1219-1227.
pmid: 26983719
|
[13] |
SASAKI R, KANDA T, YOKOSUKA O, et al. Exosomes and hepatocellular carcinoma: from bench to bedside[J]. Int J Mol Sci, 2019, 20(6): E1406.
|
[14] |
KAHLERT C, KALLURI R. Exosomes in tumor microenvironment influence cancer progression and metastasis[J]. J Mol Med (Berl), 2013, 91(4): 431-437.
doi: 10.1007/s00109-013-1020-6
pmid: 23519402
|
[15] |
XIONG L, WANG F, XIE X Q. Advanced treatment in high-grade gliomas[J]. J BUON, 2019, 24(2): 424-430.
pmid: 31127986
|
[16] |
NAN Y. Molecular targeted therapy in glioblastoma[J]. J Int Oncol, 2017, 44: 689-692.
|
[17] |
KOPP F, MENDELL J T. Functional classification and experimental dissection of long noncoding RNAs[J]. Cell, 2018, 172(3): 393-407.
doi: S0092-8674(18)30048-5
pmid: 29373828
|
[18] |
ANGELOPOULOU E, PAUDEL Y N, PIPERI C. Critical role of HOX transcript antisense intergenic RNA (HOTAIR) in gliomas[J]. J Mol Med (Berl), 2020, 98(11): 1525-1546.
doi: 10.1007/s00109-020-01984-x
|
[19] |
曲来强, 彭静, 喻磊, 等. lncRNA HOXA-AS2对视网膜母细胞瘤细胞增殖和上皮间质转化的影响[J]. 中国肿瘤临床与康复, 2021, 28(11): 1308-1311.
|
|
QU L Q, PENG J, YU L, et al. Effects of LncRNA HOXA-AS2 on the proliferation and epithelial-mesenchymal transition of retinoblastoma cells[J]. Chin J Clin Oncol Rehabilitation, 2021, 28(11): 1308-1311.
|
[20] |
陈升阳, 陈艳军, 胡水全, 等. LncRNA HOXA-AS2在胰腺癌组织中的表达及对细胞增殖和侵袭力的影响[J]. 实用医学杂志, 2021, 37(14): 1795-1799.
|
|
CHEN S Y, CHEN Y J, HU S Q, et al. Expression of lncRNA HOXA-AS2 in pancreatic cancer tissues and its effect on cell proliferation and invasion[J]. J Pract Med, 2021, 37(14): 1795-1799.
|
[21] |
ZHANG P, CAO P H, ZHU X F, et al. Upregulation of long non-coding RNA HOXA-AS2 promotes proliferation and induces epithelial-mesenchymal transition in gallbladder carcinoma[J]. Oncotarget, 2017, 8(20): 33137-33143.
doi: 10.18632/oncotarget.16561
pmid: 28388535
|
[22] |
俞盛健, 麻怀露, 陈王洋, 等. 基于生物信息学的脑胶质瘤预后风险长链非编码RNA筛选[J]. 温州医科大学学报, 2020, 50(3): 199-205.
|
|
YU S J, MA H L, CHEN W Y, et al. Bioinformatics study on the screening of long-chain noncoding RNA for prognostic risk of glioma[J]. J Wenzhou Med Univ, 2020, 50(3): 199-205.
|
[23] |
WU L X, ZHU X Q, SONG Z Y, et al. Long non-coding RNA HOXA-AS2 enhances the malignant biological behaviors in glioma by epigenetically regulating RND3 expression[J]. Onco Targets Ther, 2019, 12: 9407-9419.
doi: 10.2147/OTT.S225678
|
[24] |
GAO Y N, YU H, LIU Y H, et al. Long non-coding RNA HOXA-AS2 regulates malignant glioma behaviors and vasculogenic mimicry formation via the miR-373/EGFR axis[J]. Cell Physiol Biochem, 2018, 45(1): 131-147.
doi: 10.1159/000486253
pmid: 29310118
|
[25] |
DAI J, SU Y Z, ZHONG S Y, et al. Exosomes: key players in cancer and potential therapeutic strategy[J]. Signal Transduct Target Ther, 2020, 5(1): 145.
|
[26] |
XU J S, LIAO K L, ZHOU W M. Exosomes regulate the transformation of cancer cells in cancer stem cell homeostasis[J]. Stem Cells Int, 2018, 2018: 4837370.
|
[27] |
CONIGLIARO A, FONTANA S, RAIMONDO S, et al. Exosomes: nanocarriers of biological messages[J]. Adv Exp Med Biol, 2017, 998: 23-43.
doi: 10.1007/978-981-10-4397-0_2
pmid: 28936730
|
[28] |
WANG S S, GAO X L, LIU X, et al. CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation[J]. Oncotarget, 2016, 7(20): 29051-29062.
doi: 10.18632/oncotarget.8665
|
[29] |
CHEN W Q, ALLEN S G, QIAN W Y, et al. Biophysical phenotyping and modulation of ALDH + inflammatory breast cancer stem-like cells[J]. Small, 2019, 15(5): e1802891.
|
[30] |
JIANG Y, SONG Y F, WANG R, et al. NFAT1-mediated regulation of NDEL1 promotes growth and invasion of glioma stem-like cells[J]. Cancer Res, 2019, 79(10): 2593-2603.
doi: 10.1158/0008-5472.CAN-18-3297
pmid: 30940662
|
[31] |
CHAI Y, WU H T, LIANG C D, et al. Exosomal lncRNA ROR1-AS1 derived from tumor cells promotes glioma progression via regulating miR-4686[J]. Int J Nanomedicine, 2020, 15: 8863-8872.
doi: 10.2147/IJN.S271795
|
[32] |
YOUSEFI H, MAHERONNAGHSH M, MOLAEI F, et al. Long noncoding RNAs and exosomal lncRNAs: classification, and mechanisms in breast cancer metastasis and drug resistance[J]. Oncogene, 2020, 39(5): 953-974.
doi: 10.1038/s41388-019-1040-y
pmid: 31601996
|
[33] |
JIANG J X, LU J, WANG X L, et al. Glioma stem cell-derived exosomal miR-944 reduces glioma growth and angiogenesis by inhibiting AKT/ERK signaling[J]. Aging (Albany NY), 2021, 13(15): 19243-19259.
|
[34] |
CONIGLIARO A, COSTA V, LO DICO A, et al. CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA[J]. Mol Cancer, 2015, 14: 155.
doi: 10.1186/s12943-015-0426-x
|
[35] |
SUN Z, WANG L, ZHOU Y L, et al. Glioblastoma stem cell-derived exosomes enhance stemness and tumorigenicity of glioma cells by transferring Notch1 protein[J]. Cell Mol Neurobiol, 2020, 40(5): 767-784.
doi: 10.1007/s10571-019-00771-8
pmid: 31853695
|